Boston Scientific announced that the FDA approved two navigation-enabled ablation catheters for treatment of type I atrial flutter. The magnetically tracked catheters (IntellaNav XP and IntellaNav ...
NATICK, Mass., Boston Scientific Corporation completed a first-in-human clinical trial utilizing the IntellaTip MiFi™ XP Ablation Catheter for the treatment of type 1 atrial flutter, an arrhythmia ...
First-of-its-kind, all-in-one HD-mapping and dual energy (pulsed field and radiofrequency) ablation catheter Highly anticipated by electrophysiologists for its innovation and demonstrated safety and ...
BURLINGTON, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- CoreMap today announced it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to extend ...
CARLSBAD, Calif., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today ...
Stockhead on MSN
Health Check: Imricor shares soar on the heart device play’s second FDA clearance this month
Two weeks after giving the nod to Imricor's novel ablation catheter, the FDA has cleared the company's overriding 'dashboard' ...
Medtronic won CE mark for the Affera Sphere-360 catheter and completed the first cases of the device in the Horizon 360 IDE ...
Affera momentum continues as Medtronic announces CE Mark in Europe & US IDE first cases for Sphere-360 PFA catheter to treat paroxysmal atrial fibrillation: Galway, Ireland Tuesda ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results